Copy
View this email in your browser
Vol. 3, No. 11                                                                                                         June 3, 2020

Cancer Institute Member Spotlight

Tung-Chin Chiang, Ph.D.
Assistant Professor
Department of Environmental and Occupational Health
UAMS Fay W. Boozman College of Public Health
 
Dr. Chiang's research interest is in the impact of environmental exposure on human health via epigenetic modifications. Our susceptibility to cancers is the combination of the genetic material and epigenetic modifiers. Environmental exposures from polluted water and UV are one of the sources of epigenetic modifiers that could have an impact on our gene expression without changing genes.   Read more>
Arkansas Breast Cancer Research Program
FY21 Funding Proposals

The Arkansas Breast Cancer Research Program (ABCRP) invites you to submit breast cancer research funding proposals for FY21. ABCRP offers a one-year $50,000 pilot mechanism and a $250,000 investigator award. The number of awards that will be granted under each mechanism is not predetermined.

Applications are due Tuesday, June 30, 2020. Awards will be announced in late August 2020 with funding to begin September 1, 2020. Download RFPs at the above links or contact Jennifer Moulton if you have any questions.

Cancer-related Research Funding Opportunities
Extramural Opportunities

Notice of Special Interest (NOSI): Administrative Supplement to a Cancer Moonshot Coordinating Center (U24) to Support the Mechanisms of Cancer Drug Resistance and Sensitivity Network (DSRN)

Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19)  

Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19)

Integrating Biospecimen Science Approaches into Clinical Assay Development

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

DoD Lung Cancer, Concept Award

DoD Lung Cancer, Career Development Award
 
DoD Lung Cancer, Investigator-Initiated Translational Research Award

DoD Lung Cancer, Clinical Translational Research Partnership Award
 
Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional)

Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional)

DOD Prostate Cancer, Early Investigator Research Award

DoD Prostate Cancer, Health Disparity Research Award

DoD Prostate Cancer, Clinical Trial Award

DoD Prostate Cancer, Translational Science Award

DoD Prostate Cancer, Population Science and Outcomes Research Award

DoD Prostate Cancer, Idea Development Award

DoD Prostate Cancer, Prostate Cancer Pathology Resource Network Award

DoD Prostate Cancer, Physician Research Award

Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)

DoD Neurofibromatosis, Investigator-Initiated Research Award

DoD Neurofibromatosis, Clinical Trial Award

DoD Neurofibromatosis, Exploration – Hypothesis Development Award

DoD Neurofibromatosis, New Investigator Award

DoD Neurofibromatosis, Early Investigator Research Award

DoD Neurofibromatosis, Synergistic Idea Award

DoD, Breast Cancer, Breakthrough Award Levels 1 and 2

DoD, Breast Cancer, Breakthrough Award Level 3

DoD, Breast Cancer, Breakthrough Award Level 4
DoD, Breast Cancer, Innovator Award

DoD Breast Cancer, Era of Hope Scholar Award

DoD Breast Cancer, Transformative Breast Cancer Consortium Award

DoD Melanoma Research Program, Idea Award

DoD Melanoma Research Program, Mid-Career Accelerator Award

DoD Melanoma Research Program, Team Science Award

DoD Melanoma Research Program, Technology Development Partnership Award

DoD Melanoma Research Program, Translational Research Award

DoD Melanoma Research Program, Translational Research Award – Collaborator Option

DoD CDMRP Ovarian Cancer Research Program Ovarian Cancer Academy – Early-Career Investigator Award

DoD CDMRP Ovarian Cancer Research Program Clinical Translational Research Award

DoD CDMRP Ovarian Cancer Research Program Pilot Award

DoD CDMRP Ovarian Cancer Research Program Investigator-Initiated Research Award
 
DoD CDMRP Ovarian Cancer Proteogenomics Research Award

DoD Academy of Kidney Cancer Investigators – Early Career Investigator Award

DoD Kidney Cancer Research Program Concept Award

DoD Kidney Cancer Research Program Translational Research Partnership Award

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)

Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01)

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21)

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional)

Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)

NIH Utilizing Cohort Studies to Address Outcomes in Cancer Survivors
 

CTSA Supplemental Funding Opportunities

NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award, (U01 Clinical Trial Optional)

 
Foundation and Intramural Funding Opportunities

Mark Foundation Emerging Leader Awards
Know someone who needs to be added to our email list? Send their name to Susan Van Dusen, communications manager.
Copyright © 2021 *|LIST:COMPANY|*, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp